Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 820.41 Delayed Data As of Mar 27 |  +0.41 / +0.05%Today’s Change | 538.01 Today|||52-Week Range 832.48 | +13.71% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Stahl Neil Executive Vice President-Research & Development |  Sale | 8/04/2022 | 71,218 | $613.00 | $43.7M | +33.41% |
Van Plew Daniel P | Sale | 11/22/2022 | 38,028 | $741.81 | $28.2M | +9.50% |
Van Plew Daniel P | Sale | 9/09/2022 | 35,304 | $730.96 | $25.8M | +13.27% |
Stahl Neil Executive Vice President-Research & Development |  Buy | 8/04/2022 | 95,000 | $270.43 | $25.7M | +33.41% |
Van Plew Daniel P | Buy | 9/09/2022 | 40,000 | $555.67 | $22.2M | +13.27% |
Vagelos P Roy Director | Sale | 2/22/2023 | 29,005 | $750.16 | $21.8M | +9.67% |
Van Plew Daniel P | Sale | 11/04/2022 | 26,114 | $725.84 | $19.0M | +10.83% |
Van Plew Daniel P | Buy | 11/22/2022 | 50,000 | $378.98 | $18.9M | +9.50% |
Larosa Joseph J | Sale | 9/09/2022 | 20,730 | $730.96 | $15.2M | +13.27% |
Van Plew Daniel P | Buy | 11/04/2022 | 34,000 | $381.92 | $13.0M | +10.83% |
Page of 51